Cancer Research 2015-06-01

Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.

Chao-Ching Chang, Meng-Ju Wu, Jer-Yen Yang, Ignacio G Camarillo, Chun-Ju Chang

Index: Cancer Res. 75 , 2375-86, (2015)

Full Text: HTML

Abstract

Obesity has been linked to breast cancer progression but the underlying mechanisms remain obscure. Here we report how leptin, an obesity-associated adipokine, regulates a transcriptional pathway to silence a genetic program of epithelial homeostasis in breast cancer stem-like cells (CSC) that promotes malignant progression. Using genome-wide ChIP-seq and RNA expression profiling, we defined a role for activated STAT3 and G9a histone methyltransferase in epigenetic silencing of miR-200c, which promotes the formation of breast CSCs defined by elevated cell surface levels of the leptin receptor (OBR(hi)). Inhibiting the STAT3/G9a pathway restored expression of miR-200c, which in turn reversed the CSC phenotype to a more differentiated epithelial phenotype. In a rat model of breast cancer driven by diet-induced obesity, STAT3 blockade suppressed the CSC-like OBR(hi) population and abrogated tumor progression. Together, our results show how targeting STAT3-G9a signaling regulates CSC plasticity during obesity-related breast cancer progression, suggesting a novel therapeutic paradigm to suppress CSC pools and limit breast malignancy.©2015 American Association for Cancer Research.

Related Compounds

Structure Name/CAS No. Articles
S3I-201 Structure S3I-201
CAS:501919-59-1
Leptin (human), (recombinant) Structure Leptin (human), (recombinant)
CAS:177404-21-6
Hydrocortisone Structure Hydrocortisone
CAS:50-23-7
CGS-12066 maleate Structure CGS-12066 maleate
CAS:1350965-83-1
Leptin (mouse), (recombinant) Structure Leptin (mouse), (recombinant)
CAS:181030-10-4